CHAF1B: the hidden culprit behind sorafenib resistance in hepatocellular carcinoma
International Journal of Medical Sciences · 2025
DOI: 10.7150/ijms.118471 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Wenfeng Zhuo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, the Fifth Affiliated Hospital, Sun Yat-sen University 519000 Zhuhai, Guangdong, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Sorafenib, Liver Neoplasms, Drug Resistance, Neoplasm. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, the Fifth Affiliated Hospital, Sun Yat-sen University 519000 Zhuhai, Guangdong, China.
- Department of Urology Surgery, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, Guangdong, China.
Zitieren
APA
Zhuo, W., Zhao, J., Zheng, Z., Cai, S., Zeng, G., Lin, E., Bai, Z., Wang, B., Jia, Y., Li, P., & Li, J. (2025). CHAF1B: the hidden culprit behind sorafenib resistance in hepatocellular carcinoma. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.118471
Vancouver
Zhuo W, Zhao J, Zheng Z, Cai S, Zeng G, Lin E, et al. CHAF1B: the hidden culprit behind sorafenib resistance in hepatocellular carcinoma. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.118471
BibTeX
@article{Zhuo2025,
author = {Zhuo, Wenfeng and Zhao, Jiali and Zheng, Zhouying and Cai, Shanglin and Zeng, Guifang and Lin, En and Bai, Zirui and Wang, Bo and Jia, Yingbin and Li, Peiping and Li, Jian},
title = {CHAF1B: the hidden culprit behind sorafenib resistance in hepatocellular carcinoma},
journal = {International Journal of Medical Sciences},
year = {2025},
doi = {10.7150/ijms.118471}
}
EUVIMED